Areva Pharma

Areva Pharmaceuticals, a family-owned Women-owned Minority-owned enterprise, takes pride in being a part of the movement to support diversity in the US healthcare system. We are committed to setting higher goals and bringing innovation to help our healthcare partners succeed in treating patients. As a Women-run business, we strive to make a difference in the pharmaceutical industry, which has historically been slow to support Women-owned enterprises.

Founded in 2007, Areva Pharmaceuticals began commercial operations in November 2011, and since then, we have been producing and distributing high-quality, affordable generic pharmaceutical products. Our state-of-the-art production facilities are subject to strict standards and are regularly inspected to ensure current Good Manufacturing Compliance (cGMP). Our commitment to quality is unwavering, and our medicines adhere to the same standards of quality, efficacy, and safety as that of the originator product.

Quality Generics

Areva Pharmaceuticals is the leading producer of pharmaceutical products, with a reputation for producing the highest quality, affordable medicines. Our business is producing and distributing generic pharmaceutical products for patients in the United States. We believe that every patient deserves access to affordable, high-quality healthcare, and we are committed to delivering on that promise.

Our generic pharmaceutical products are tightly controlled and monitored by Areva associates, and are subject to inspection by the relevant regulatory authorities. We take our responsibility to maintain the highest standards of quality and safety very seriously. Our medicines adhere to the same standards of quality, efficacy, and safety as that of the originator product. With advanced production facilities that are regularly inspected, Areva stands out as the quality leader of affordable pharmaceutical products.

Oncology Injectables & Oral Solids

Areva specializes in delivering high-quality oncology injectables and oral solids. These products go a step beyond standard generics and are designed to be safe and user-friendly to administer, helping to reduce human error. Our commitment to producing high-quality oncology injectables and oral solids is evident in the significant resources we have invested in manufacturing facilities that are the most advanced in the world.

Our facilities ensure highly sterile environments and the containment of raw material and product at every stage of the development and production process. Given the high degree of toxicity in the production process, producing high-quality, safe oncology injectables and oral solids is a challenging task. However, Areva has more than met this challenge by committing significant resources towards manufacturing facilities that are the most advanced in the world.

At Areva Pharmaceuticals, we are dedicated to providing innovative, high-quality, and affordable pharmaceutical products. We continuously strive to develop and market new products that address the needs of patients across the world. As we expand into new markets, we are committed to finding experienced, ambitious, and innovative individuals who share our passion for quality and innovation to join our team.